Over the past several decades, business has increasingly become a catalyst for biological innovation. Since the advent of recombinant DNA technology, where the scientific mind of H. Boyer met the business mind of B. Swanson, business and biology have taken a hand-in-hand approach to bringing ground-breaking technologies to the forefront of human endeavor. This mutualistic experience has allowed for the businesses to turn profits and for scientists to further push the envelope of what is possible.